title: A case of severe acute pancreatitis treated with CTR-001 direct hemoperfusion for cytokine apheresis.
abstract: Severe acute pancreatitis is a clinical entity that can develop into multiple organ failure (MOF), and still has a poor prognosis. It is generally agreed that excessive humoral mediators such as pro-inflammatory cytokines play important roles in the pathogenesis of organ failure in patients with severe acute pancreatitis (SAP). Furthermore, it has been reported that continuous hemodiafiltration (CHDF) can remove the excess humoral mediators during the hypercytokinemic state of systemic inflammatory response syndrome (SIRS). We experienced a case of severe acute pancreatitis induced by alcohol abuse, on whom we performed cytokine apheresis. The patient was a 46 year-old male. He received 14 cytokine apheresis procedures, for about 4 hours in each session, using a CTR-001 direct hemoperfusion (DHP) cartridge. His serum levels of pro-inflammatory cytokines such as interleukin-6 (IL-6; 1649.1+/-667.1-1257.1+/-489.4 pg/mL, P=0.013) decreased significantly after the CTR-001 procedures. However tumor necrosis factor-alpha (TNF-alpha) (26.2+/-1.7-24.3+/-1.9 pg/mL, P=0.087), IL-1beta (6.1+/-2.9-3.49+/-1.1 pg/mL, P=0.477), IL-8 (192.5+/-33.4-229.5+/-51.8 pg/mL, P=0.754) and IL-10 (14.4+/-2.7-14.0+/-1.9 pg/mL, P=0.726) did not decrease statistically. Therefore, we conclude that in this case, cytokine apheresis using a CTR-001 cartridge was effective for reducing the pro-inflammatory cytokines during severe acute pancreatitis.
authors.affiliation: Critical and Intensive Care Medicine, Shiga University of Medical Science, Shiga, Japan. saotome@belle.shiga-med.ac.jp
authors.forename: Takao
authors.initials: T
authors.lastname: Saotome
authors.forename: Yoshihiro
authors.initials: Y
authors.lastname: Endo
authors.forename: Teiji
authors.initials: T
authors.lastname: Sasaki
authors.forename: Takahisa
authors.initials: T
authors.lastname: Tabata
authors.forename: Tetsu
authors.initials: T
authors.lastname: Hamamoto
authors.forename: Kazunori
authors.initials: K
authors.lastname: Fujino
authors.forename: Akira
authors.initials: A
authors.lastname: Andoh
authors.forename: Yutaka
authors.initials: Y
authors.lastname: Eguchi
authors.forename: Tohru
authors.initials: T
authors.lastname: Tani
authors.forename: Yoshihide
authors.initials: Y
authors.lastname: Fujiyama
mesh_terms: D000208:Acute Disease; D000328:Adult; D001781:Blood Component Removal / Q000295:instrumentation*; D016207:Cytokines / Q000097:blood*; D006464:Hemoperfusion / Q000295:instrumentation*; D006801:Humans; D008297:Male; D010195:Pancreatitis / Q000097:blood / Q000628:therapy*; D018709:Statistics, Nonparametric
chemical_list: D016207:Cytokines